Drug Discovery

The landscape of therapeutic discovery is undergoing a seismic shift as artificial intelligence moves from being a mere digital assistant to becoming the very architecture upon which modern biology is built. Anthropic has recently solidified this transition by announcing the acquisition of

The biological resilience of pancreatic ductal adenocarcinoma (PDAC) has long earned it a reputation as the "impenetrable fortress" of oncology, maintaining a lethal grip on patients despite decades of intensive global research. While the discovery of ferroptosis—a specialized, iron-dependent form

Ivan Kairatov is a leading biopharma expert with an extensive background in research and development, specializing in the intersection of biotechnology and advanced computational innovation. With a career dedicated to unraveling the complexities of the human genome and neurodegenerative

The biological machinery responsible for filtering waste sometimes malfunctions so catastrophically that routine metabolic processes turn into a source of systemic internal damage. Primary Hyperoxaluria represents a group of rare, inherited metabolic disorders that force the body into a state of

The architecture of a malignant tumor is more than just a cluster of runaway cells; it is a sophisticated, oxygen-starved fortress designed to withstand the body’s most potent immune responses. For decades, oncologists have struggled to breach these "hypoxic" zones, where low oxygen levels trigger

The landscape of modern oncology is currently witnessing a tectonic shift as clinical researchers increasingly abandon the cumbersome laboratory-based cell modification protocols that have defined the last decade. For several years, the medical community viewed Chimeric Antigen Receptor (CAR)